Logo

LGC to Market Gentris' GentriSure Controls in Europe, Asia

Dec 21, 2006
NEW YORK (GenomeWeb News) — Gentris today said that London-based reference materials company LGC Promochem will market its GentriSure products to labs in Europe and India.
 
Gentris, a genotyping products and services company based in Morrisville, NC, said the human genomic reference controls now contain polymorphisms for the CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes. The firm added that they are derived from human donors and do not include artificial DNA sequences.   
 
Financial terms of the deal were not released.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.